论文部分内容阅读
选取我院收治的高血压糖尿病患者80例,随机分为对照组给予厄贝沙坦治疗;观察组在对照组基础上给予硝苯地平缓释片治疗。结果:对照组和观察组患者SBP、DBP均比治疗前降低(P<0.05),且观察组下降程度比对照组显著(P<0.05);观察组总有效率为95%,高于对照组(82.5%)(P<0.05)。结论:硝苯地平缓释片应用于高血压糖尿病时具有良好的降压作用,安全可靠。
Eighty patients with hypertensive diabetes admitted to our hospital were randomly divided into control group and treated with irbesartan. The observation group was given nifedipine sustained-release tablets on the basis of the control group. Results: The SBP and DBP of the control group and the observation group were lower than those before treatment (P <0.05), and the degree of decrease in the observation group was significantly higher than that in the control group (P <0.05). The total effective rate in the observation group was 95% (82.5%) (P <0.05). Conclusion: Nifedipine sustained-release tablets have a good antihypertensive effect in hypertensive diabetic patients, which is safe and reliable.